Parallel Bio
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Founded in 1/1/21
Cambridge, Massachusetts, United States
For Profit
About Parallel Bio
Parallel Bio develops tools that help in the discovery and development of immunotherapies, to eliminate current barriers and create the fastest path to a drug that works. Parallel Bio's platform combines best-in-class human immune organoids with computational methods to generate unprecedented insights into human health and disease.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 4625000 USD
- Last Funding: 4300000 USD (Seed)
- Funding Status: Seed
Technology Stack
Parallel Bio actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Life Science, Pharmaceutical, Therapeutics
Headquarters: Cambridge, Massachusetts, United States
Leadership
- Robert Difazio - Co-Founder & CEO LinkedIn
Employees
- Juliana Hilliard - Co-Founder & CSO (LinkedIn)